Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Effect on Neural Responses to HFCS in Obesity
NCT03500484Phase 1Terminated
- Sponsor
- Yale University
- Start
- Jun 2018
- Primary completion
- Jun 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label trial of liraglutide in obesity (2 arms), sponsored by Yale University. Primary endpoints: Brain Response in Obese Young Adults Who Drink Sugar Sweetened Beverages at 1 week and Change in Brain Response in Obese Young Adults Who Drink Sugar Sweetened Beverages at 12 weeks. Started Jun 2018; status: terminated.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03500484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500484.